Showing results (411-420 of 941) with videos related to

Sort By:
Pageof 95
Neurology and Therapy|September 13, 2024
Advancements and Challenges in Exercise Training for Multiple Sclerosis: Comprehensive Review and Future Directions for Randomized Controlled TrialsRobert W Motl, Lara A Pilutti
Neurology and Therapy|September 18, 2024
Estimating the Economically Justifiable Price of Limited-Duration Treatment with Donanemab for Early Symptomatic Alzheimer's Disease in the United StatesMalaz Boustani, Erin G Doty, Louis P Garrison, et al.
Neurology and Therapy|September 9, 2024
Phase 1 Trials of Gatralimab, a Next-Generation Humanized Anti-CD52 Monoclonal Antibody, in Participants with Progressive Multiple SclerosisFredrik N Albach, Christian Geier, Christian Keicher, et al.
Neurology and Therapy|March 1, 2024
The Association Between National Institutes of Health Stroke Scale Score and Clinical Outcome in Patients with Large Core Infarctions Undergoing Endovascular TreatmentLingyu Zhang, Jinfu Ma, Mengmeng Wang, et al.
Neurology and Therapy|February 20, 2024
Summary of Research: What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot FoundationSarah A Morrow, Paola Kruger, Dawn Langdon, et al.
Neurology and Therapy|February 16, 2024
Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective StudyTaoufik Alsaadi, Reem Suliman, Vanessa Santos, et al.
Neurology and Therapy|October 24, 2023
Recognition and Practice of Hypopituitarism After Traumatic Brain Injury and Subarachnoid Hemorrhage in Japan: A SurveyShigeyuki Tahara, Fumio Otsuka, Takaaki Endo
Neurology and Therapy|July 14, 2023
The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis TreatmentStephen L Hauser, Ludwig Kappos, Amit Bar-Or, et al.
Neurology and Therapy|July 19, 2023
What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot FoundationSarah A Morrow, Paola Kruger, Dawn Langdon, et al.
Neurology and Therapy|July 19, 2023
Potential Ocular Biomarkers for Early Detection of Alzheimer's Disease and Their Roles in Artificial Intelligence StudiesPareena Chaitanuwong, Panisa Singhanetr, Methaphon Chainakul, et al.
Pageof 95